These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37574645)

  • 21. Convenience and comfort: reasons reported for using drugs alone among clients of harm reduction sites in British Columbia, Canada.
    Papamihali K; Yoon M; Graham B; Karamouzian M; Slaunwhite AK; Tsang V; Young S; Buxton JA
    Harm Reduct J; 2020 Nov; 17(1):90. PubMed ID: 33228676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. "The system always undermined what I was trying to do as an individual": identifying opportunities to improve the delivery of opioid use services for youth from the perspective of service providers in four communities across British Columbia, Canada.
    Marchand K; Turuba R; Katan C; Fogarty O; Fairbank J; Tallon C; Mathias S; Barbic S
    Addict Sci Clin Pract; 2023 Jan; 18(1):1. PubMed ID: 36593469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterizing safer supply prescribing of immediate release hydromorphone for individuals with opioid use disorder across Ontario, Canada.
    Young S; Kolla G; McCormack D; Campbell T; Leece P; Strike C; Srivastava A; Antoniou T; Bayoumi AM; Gomes T
    Int J Drug Policy; 2022 Apr; 102():103601. PubMed ID: 35124413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "It's Helped Me a Lot, Just Like to Stay Alive": a Qualitative Analysis of Outcomes of a Novel Hydromorphone Tablet Distribution Program in Vancouver, Canada.
    Ivsins A; Boyd J; Mayer S; Collins A; Sutherland C; Kerr T; McNeil R
    J Urban Health; 2021 Feb; 98(1):59-69. PubMed ID: 33118145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Negative changes in illicit drug supply during COVID-19: Associations with use of overdose prevention and health services among women sex workers who use drugs (2020-2021).
    Moreheart S; Shannon K; Krüsi A; McDermid J; Ettinger E; Braschel M; Goldenberg SM
    Int J Drug Policy; 2023 Nov; 121():104212. PubMed ID: 37797570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What is needed for implementing drug checking services in the context of the overdose crisis? A qualitative study to explore perspectives of potential service users.
    Wallace B; van Roode T; Pagan F; Phillips P; Wagner H; Calder S; Aasen J; Pauly B; Hore D
    Harm Reduct J; 2020 May; 17(1):29. PubMed ID: 32398090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of an integrated safer use space and safer supply program on non-fatal overdose among emergency shelter residents during a COVID-19 outbreak: a case study.
    Lew B; Bodkin C; Lennox R; O'Shea T; Wiwcharuk G; Turner S
    Harm Reduct J; 2022 Mar; 19(1):29. PubMed ID: 35313903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. "As long as that place stays open, I'll stay alive": Accessing injectable opioid agonist treatment during dual public health crises.
    Jaffe K; Blawatt S; Lehal E; Lock K; Easterbrook A; MacDonald S; Harrison S; Lajeunesse J; Byres D; Schechter M; Oviedo-Joekes E
    Harm Reduct J; 2023 Apr; 20(1):51. PubMed ID: 37060027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigating opioid preference to inform safe supply services: A cross sectional study.
    Ferguson M; Parmar A; Papamihali K; Weng A; Lock K; Buxton JA
    Int J Drug Policy; 2022 Mar; 101():103574. PubMed ID: 35007878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Access to tablet injectable opioid agonist therapy in rural and smaller urban settings in British Columbia, Canada: a qualitative study.
    Bardwell G; Bowles JM; Mansoor M; Werb D; Kerr T
    Subst Abuse Treat Prev Policy; 2023 Mar; 18(1):14. PubMed ID: 36869358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluating networked drug checking services in Toronto, Ontario: study protocol and rationale.
    Maghsoudi N; McDonald K; Stefan C; Beriault DR; Mason K; Barnaby L; Altenberg J; MacDonald RD; Caldwell J; Nisenbaum R; Leece P; Watson TM; Tupper KW; Kufner L; Scheim AI; Werb D;
    Harm Reduct J; 2020 Jan; 17(1):9. PubMed ID: 32204713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating the sector-wide implementation of virtual child and youth mental health services in response to the COVID-19 pandemic: Perspectives from service providers, agency leaders and clients.
    Danseco E; Kurzawa J; Sundar P; Brown J; Huang C
    Implement Res Pract; 2021; 2():26334895211045690. PubMed ID: 37089999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diverse psychotropic substances detected in drug and drug administration equipment samples submitted to drug checking services in Toronto, Ontario, Canada, October 2019-April 2020.
    Scarfone KM; Maghsoudi N; McDonald K; Stefan C; Beriault DR; Wong E; Evert M; Hopkins S; Leslie P; Watson TM; Werb D;
    Harm Reduct J; 2022 Jan; 19(1):3. PubMed ID: 35012557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Towards cross-Canada monitoring of the unregulated street drug supply.
    Biggar E; Papamihali K; Leclerc P; Hyshka E; Graham B; Taylor M; Payer D; Maloney-Hall B; Buxton JA
    BMC Public Health; 2021 Sep; 21(1):1678. PubMed ID: 34525994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implementation of Safe Supply Alternatives During Intersecting COVID-19 and Overdose Health Emergencies in British Columbia, Canada, 2021.
    McNeil R; Fleming T; Mayer S; Barker A; Mansoor M; Betsos A; Austin T; Parusel S; Ivsins A; Boyd J
    Am J Public Health; 2022 Apr; 112(S2):S151-S158. PubMed ID: 35262376
    [No Abstract]   [Full Text] [Related]  

  • 37. Factors associated with 60-day adherence to "safer supply" opioids prescribed under British Columbia's interim clinical guidance for health care providers to support people who use drugs during COVID-19 and the ongoing overdose emergency.
    Selfridge M; Card K; Kandler T; Flanagan E; Lerhe E; Heaslip A; Nguyen A; Moher M; Pauly B; Urbanoski K; Fraser C
    Int J Drug Policy; 2022 Jul; 105():103709. PubMed ID: 35525052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feasibility, acceptability, concerns, and challenges of implementing supervised injection services at a specialty HIV hospital in Toronto, Canada: perspectives of people living with HIV.
    Rudzinski K; Xavier J; Guta A; Chan Carusone S; King K; Phillips JC; Switzer S; O'Leary B; Baltzer Turje R; Harrison S; de Prinse K; Simons J; Strike C
    BMC Public Health; 2021 Jul; 21(1):1482. PubMed ID: 34325681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Harm reduction via online platforms for people who use drugs in Russia: a qualitative analysis of web outreach work.
    Davitadze A; Meylakhs P; Lakhov A; King EJ
    Harm Reduct J; 2020 Dec; 17(1):98. PubMed ID: 33298081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The potential impacts of community drug checking within the overdose crisis: qualitative study exploring the perspective of prospective service users.
    Wallace B; van Roode T; Pagan F; Hore D; Pauly B
    BMC Public Health; 2021 Jun; 21(1):1156. PubMed ID: 34134698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.